Ms. Shan joined Athyrium in 2020 and currently serves as an Associate.
Prior to joining Athyrium, Ms. Shan was an investment banking analyst in the Strategic Advisory Group at PJT Partners. While at PJT, Ms. Shan advised biotechnology and pharmaceutical companies on a number of mergers and acquisitions transactions, strategic initiatives and licensing opportunities.
Ms. Shan graduated from the Roy and Diana Vagelos Program at the University of Pennsylvania in 2017, where she earned a B.A. in Chemistry from the College of Arts and Sciences and a B.S. in Economics from the Wharton School.